New device aims to sharpen precision of liver cancer radiation
NCT ID NCT07444645
Summary
This study is testing a new catheter system called TriNav to see if it can improve the delivery of targeted radiation treatment (Y90 radioembolization) to liver tumors. Researchers will compare how well the new system delivers a special dye to tumors versus a standard catheter, using CT scans. The goal is to see if the new system helps focus more radiation on the tumor while protecting healthy liver tissue.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.